ReviewTargeted oncology2020
Gilteritinib: A Review in Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukaemia.
Connie Kang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewTargeted oncology2020
Connie Kang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.